Both activated Akt and Ser897-phosphorylated EphA2 are robustly expressed in GBM tissues, and an interaction of EphA2 with AKT is associated with the malignant progression of glioma (Miao et al., 2009). This evidence concerns the gene EPHA2 and glioma.